Marcia Bergeron's death by counterfeit-drug metal toxicity () is a reminder that , writes former Health Canada science advisory board member Leslie Millin in an editorial in today's Sudbury Star:
"Pharmacare would have been, in fact, a small step 40 years ago, when the administration of pharmaceuticals was a much smaller proportion of medical care. Now, because of the advancement of medical science and the inexorable industrialization of the pharmaceutical industry for profit, pharmacare would be a very large dose indeed.Photo of Ms Bergeron: handout photo
"But it is not going to get any smaller."
Check out our website: